SCHEMBL30494229

SCHEMBL30494229

O=c1cc(-c2cccnc2)cc[nH]1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 1/20 0.61
▸ CYP1A2 P05177 5/20 0.54
▸ CYP2A6 P11509 2/20 0.54
▸ ALDH1A1 P00352 2/20 0.54
▸ CYP3A4 P08684 2/20 0.54
▸ KMO O15229 1/20 0.51
▸ AURKA O14965 1/20 0.51
▸ TTK P33981 1/20 0.51
▸ AURKB Q96GD4 1/20 0.51
▸ INCENP Q9NQS7 1/20 0.51
▸ CYP11B1 P15538 6/20 0.50
▸ CYP11B2 P19099 6/20 0.50
▸ TDP2 O95551 1/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ PSIP1 O75475 1/20 0.49
▸ AXL P30530 1/20 0.49
▸ MKNK1 Q9BUB5 1/20 0.49
▸ MKNK2 Q9HBH9 1/20 0.49
▸ QPCT Q16769 1/20 0.47
▸ QPCTL Q9NXS2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26462950 1.00 NOTUM (0.61) NOTUMCYP1A2CYP2A6ALDH1A1CYP3A4
SCHEMBL1422535 0.80 CHRNB2 (0.64) CYP1A2ALDH1A1CYP3A4CYP2C9
SCHEMBL1423067 0.80 CHRNB2 (0.64) ALDH1A1
Hydrochloric Acid SCHEMBL1423348 0.79 CHRNB2 (0.62) CYP1A2ALDH1A1CYP3A4CYP2C9
Hydrochloric Acid SCHEMBL1422679 0.79 CHRNB2 (0.62) ALDH1A1
SCHEMBL6042142 0.78 NOTUM (0.77) NOTUMPDE3BPDE3A
SCHEMBL13741481 0.78 CYP19A1 (0.44) NOTUMCYP1A2CYP19A1PIK3C3MAPK1
SCHEMBL2562110 0.77 CYP1A2 (0.62) CYP1A2CYP2A6ALDH1A1CYP3A4KMO
SCHEMBL6042144 0.77 NOTUM (0.64) NOTUMCYP1A2ALDH1A1CYP3A4AURKA
SCHEMBL1136802 0.77 NOTUM (1.00) NOTUMKMOAURKATTKAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250236613-A1 SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2025-07-24 — — US disclosed
EP-4423067-A1 SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-09-04 — — EP disclosed
CN-118176181-A SARM1 modulators, their preparation and use 维泰瑞隆有限公司 2024-06-11 — — CN disclosed
WO-2023072026-A1 SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-05-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250236613-A1 SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF SARM1, ADRM1, SMN1; SMN2 NOTUM 4288/4885CYP1A2 4791/4885CYP2A6 4818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback